Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis Congenita

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01001598
Recruitment Status : Terminated (Study was terminated due to under enrollment)
First Posted : October 26, 2009
Last Update Posted : September 15, 2014
Information provided by (Responsible Party):
Colin Sieff, Children's Hospital Boston

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : May 2014
  Actual Study Completion Date : May 2014